Treatments · Entity Annotation Prototype (beta)

2articles mentioning treatments

2treatment mentions

1distinct treatments extracted

0%of mentions human-reviewed

Active filtersEntity: anti-PD1 treatment ×

anti-PD1 treatment

This treatment is selected. Its supporting articles are shown below.

anti-PD1 treatment2

Articles mentioning anti-PD1 treatment

2 articles · page 1 of 1

561 A Phase 1/2 study to evaluate the safety, tolerability, pharmacokinetics, and efficacy of TNG260 in combination with pembrolizumab in patients with STK11-mutated advanced solid tumors

jitc · abstract · 2025-11-04 · 1 matching annotations

86.1%

anti-PD1 treatment immune checkpoint therapy TNG260 pembrolizumab

…t CoREST inhibition by TNG260 sensitizes STK11-mutant tumors to anti-PD1 treatment. TNG260, in combination with pembrolizumab, is being evaluated …

633 Discovery of HDM2021 as a highly potent CBL-B inhibitor for cancer treatment

jitc · abstract · 2025-11-04 · 1 matching annotations

77.7%

anti-PD1 treatment HDM2021 Cancer Res